Microglial subtypes in neurodegeneration — friend vs foe
PARTIALLY ADDRESSED
Analyze the spectrum of microglial activation states (DAM, homeostatic, inflammatory) and their distinct roles in AD, PD, and ALS. Identify pharmacological targets for shifting microglia toward protective phenotypes.
Priority: 0.88Domain: neuroscienceHypotheses: 2
📊 Landscape Analysis
Landscape Summary:
Microglial subtypes in neurodegeneration — friend vs foe is a 0.88 priority gap in neuroscience.
It has 2 linked hypotheses with average composite score 0.623.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
Microglial subtypes in neurodegeneration — friend vs foe — INVOKE-2 (completed)